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Introduction
Xanthomonas maltophilia is a nonfermentative Gram-negative bacillus that is in-
frequently isolated in clinical microbiology laboratories. This organism is an opportu-
nistic pathogen that principally affects patients compromised by debilitating illness,
surgical procedures, or indwelling catheters (Elting et ai, 1990). The incidence of
clinical isolation of X. maltophilia is increasing, possibly in part because of the selective
pressure from some new antimicrobial agents (Marshall et al., 1989). Strains of
X. maltophilia are usually resistant to aminoglycosides and most /Mactams, show
variable susceptibility to fluoroquinolones and are generally susceptible to trimetho-
prim/sulphamethoxazole (Neu, Saha & Chin, 1989; Lecso-Bornet et al., 1992). Low
outer membrane permeability and constitutive overproduction of /J-lactamase appears
to be responsible for the generally high degree of antibiotic resistance (Mett et al.,
1988).
A reliable typing system would help in the better understanding of the epidemiology
of X. maltophilia infections. In addition, the nosocomial spread of outbreak isolates has
been suggested, but the lack of a satisfactory typing method is an important obstacle to
addressing such an epidemiological issue (Khardori et al., 1990). The purpose of the
present study was to determine the in-vitro susceptibility patterns to some new
fluoroquinolones and /f-lactams of 30 strains of X. maltophilia collected from three
countries and evaluate the potential of restriction fragment length polymorphisms
(RFLP) of chromosomal DNA (chrDNA) for epidemiological typing.
Materials and methods
We tested 30 clinical isolates from three countries: 11 from the USA (University of
Iowa Hospitals and Clinics, Iowa City, IA), eight from Brazil (Escola Paulista de
Medicina, Sao Paulo) and 11 from Switzerland (Kantonsspital Basel University Clinics,
Basel). With the exception of four Brazilian isolates (numbers 14 to 17) which were
collected from an outbreak in a dialysis unit, all other isolates were epidemiologically
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unrelated. All isolates were identified by conventional tests for motility, oxidase,
dihydrolase, and by AP120E system (Analytab Products, Plainview, USA).
MICs were determined by broth microdilution using cation-adjusted Mueller-Hinton
broth as described by the National Committee for Clinical Laboratory Standards
(1990). The agents tested were: ciprofloxacin (Miles Pharmaceuticals, West Haven,
USA); levofloxacin, ofloxacin and FK-037 (Neu, Chin & Huang, 1993) (R. W. Johnson
Research Institute, Raritan, USA); OPC-17116 (Sader, Erwin & Jones, 1992) (Otsuka
America Pharmaceuticals, Rockville, USA); cefepime (Bristol-Myers Squibb Co.,
Syracuse, USA); ceftazidime (Glaxo Laboratories, Research Triangle Park, USA);
biapenem (Lederle Laboratories, Pear River, USA); imipenem (MSD Research
Laboratories, West Point, USA); meropenem (ICI Pharmaceuticals, Wilmington,
USA).
RFLP of chrDNA was determined using the procedure previously used for
Pseudomonas aeruginosa (Sader et al., 1993). After growing the cells in trypticase soy
broth to the exponential phase, they were pelleted by centrifugation, washed and mixed
with 2% agarose (SeaPlaque GTG, FMC, Rockland, USA) to a final 1% agarose
concentration. The plugs were then incubated in 100 mM EDTA-1M NaCl-6 mM Tris,
pH 7-5 overnight at 37°C and then equilibrated with 100 mM Tris-lOOmM EDTA,
pH7-5 (TE). The plugs were then incubated in 1% sarkosyl-0-4 M EDTA, pH 9-3,
overnight at 50°C, equilibrated with TE and stored at 5°C until used. Restriction
digestion of genomic DNA was performed with either Xba\ or Spe\ (New England
Biolabs, Beverly, USA). Plugs containing digested DNA were loaded into 1 % agarose
gel and run in 50 mM Tris, 100 mM EDTA, 50 mM borate buffer. Restriction fragments
were separated by pulsed-field gel electrophoresis using a CHEF-DR II System (Bio-
Rad Laboratories, Richmond, USA). Pulse time was ramped from 10 to 90 sec for 24 h.
Results and discussion
All isolates were susceptible to trimethoprin/sulphamethoxazole (data not shown). The
Table summarizes the in-vitro activity of the four fluoroquinolones and six /?-lactams
Table. In-vitro activity of broad-spectrum /J-lactams and fluoroquinolones against 30
X. mattophilia isolates
Antimicrobial
agents
OPC-17116
Levofloxacin
Ofloxacin
Ciprofloxacin
Ceftazidime
Cefepime
FK 037
Meropenem
Biapenem
Imipenem
range
0 0 6 - > 4
0-25- > 4
1 - > 4
1 - > 2
1 - > 16
2 - > 16
4 - > 16
2 - > 8
> 8
> 8
MIC (mg/L)
MICM
0-5
2
4
>2
16
> 16
> 16
oo
 oo
 oo
A
 
A
 A
MICW
4
4
> 4
> 2
> 16
> 16
> 16
oo
 oo
 oo
A
 
A
 A
Percent susceptible
(breakpoint0 (mg/L))
83 ( =S 2)
63 ( ^ 2)
43 ( < 2)
3 ( ^ 1 )
3 7 ( ^ 8 )
30 (*S 8)
7 (*J8 )
3 ( s£4 )
0(*£4)
0 ( ^ 4 )
The breakpoints for ciprofloxacin. ofloxacin. ceftazidime and imipenem were according to NCCLS (1990)
recommendations. The breakpoints for the newer agents were based on breakpoints established for
compounds with similar chemical and pharmacokinetic characteristics.
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Figure. Restriction fragment length polymorphism analysis of chromosomal DNA after digestion with
Xba\. Epidemiologically unrelated strains of X. maltophilia show a great variety of patterns. Four Brazilian
strains isolated from an outbreak (strains 14 to 17) share a similar pattern, two of them being identical
(strains 14 and 15)
tested against the 30 X. maltophilia isolates. This genomically diverse sample from three
geographically distinct areas provided a broad view of the antimicrobial susceptibility
of the species. OPC-17116 was the most active new agent tested, with 25 isolates having
an MIC <.2 mg/L. However, the activity of the fluoroquinolones varied, with only one
isolate having a ciprofloxacin MIC < 2 mg/L. Among currently marketed drugs,
ofloxacin was the most active. The four Brazilian isolates from the outbreak shared a
very similar antimicrobial susceptibility pattern within one log2 dilution for all
compounds except levofloxacin (data not shown).
Our results agreed with other studies (Mett et al., 1988; Neu et al., 1989) that
demonstrated the poor activity of the broad-spectrum /Mactams against X. maltophilia.
Among the /?-lactams tested, ceftazidime was the most active compound; however, only
11 of 30 isolates were susceptible (MIC <, 8 mg/L). The carbapenems also demon-
strated poor activity with all but one isolate being resistant to the three compounds
tested. Because carbapenems have a broad spectrum of activity, colonization or
superinfection with resistant bacterial species is usually rare. However, exposure to
imipenem has been demonstrated to be a risk factor for acquisition of X. maltophilia
infection (Elting et al., 1990). Our results suggest that biapenem and meropenem may
also present a similar risk factor for X. maltophilia superinfection.
The Figure shows the RFLP patterns demonstrated by the X. maltophilia isolates
after digestion with Xba\. The epidemiologically unrelated isolates from three different
countries demonstrated a remarkable variety of patterns. In contrast the four Brazilian
isolates from a single outbreak presented a similar pattern, with two of them being
identical (isolates 14 and 15). Digestion with Spe\ produced essentially the same results
(data not shown). The RFLP of chrDNA thus shows potential as a method for
epidemiological X. maltophilia typing. This technique has produced excellent results for
epidemiological typing of other species (Sader et al., 1993). The reproducibility appears
to be very high, since the number and locations of the restriction sites depend only on
the genomic nucleotide sequence. The sensitivity and specificity can be adjusted by
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varying the enzyme used for cleavage. The use of low-frequency-cleavage enzymes gives
a small number of bands, allowing a more precise comparison of electrophoretic
patterns, but reducing the ability to demonstrate small genomic differences between
isolates. On the other hand, high-frequency-cleavage endonuclease increases the
number of bands, but the electrophoretic patterns can become too complex for routine
analysis. The pattern of the bands can also be adjusted by varying the instruments
switch time. Larger DNA molecules take more time to realign after the fields are
switched than do the smaller ones. Consequently, short switch times affect the
migration of larger molecules more than they affect smaller ones, increasing the
distance between them. This helps arrange the pattern in a more suitable way for
comparison.
In conclusion, our results show the potential of RFLP for epidemiological typing
X. maltophilia species and illustrate the poor activity of the new broad-spectrum
/?-lactams against this species.
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